[go: up one dir, main page]

TR201101874A2 - Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri. - Google Patents

Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.

Info

Publication number
TR201101874A2
TR201101874A2 TR2011/01874A TR201101874A TR201101874A2 TR 201101874 A2 TR201101874 A2 TR 201101874A2 TR 2011/01874 A TR2011/01874 A TR 2011/01874A TR 201101874 A TR201101874 A TR 201101874A TR 201101874 A2 TR201101874 A2 TR 201101874A2
Authority
TR
Turkey
Prior art keywords
mycobacterium
treatment
brumae
cell wall
superficial bladder
Prior art date
Application number
TR2011/01874A
Other languages
English (en)
Inventor
Leyla A�An Nac�Ye
Haluk �Zen Abdurrah�M
B�Ber Esra
Tanil Kocag�Z Z�Ht�
Ert�Rk Zel�Ha
Orhan Ba�Nu
Sel�Uk Kesk�N Mehmet
Alp Alpaslan
Sariba� Zeynep
Stara Y�Ksel Zehra
Original Assignee
Leyla A�An Nac�Ye
Haluk �Zen Abdurrah�M
B�Ber Esra
Tanil Kocag�Z Z�Ht�
Stara Y�Ksel Zehra
Orhan Ba�Nu
Sel�Uk Kesk�N Mehmet
Alp Alpaslan
Sariba� Zeynep
Ert�Rk Zel�Ha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leyla A�An Nac�Ye, Haluk �Zen Abdurrah�M, B�Ber Esra, Tanil Kocag�Z Z�Ht�, Stara Y�Ksel Zehra, Orhan Ba�Nu, Sel�Uk Kesk�N Mehmet, Alp Alpaslan, Sariba� Zeynep, Ert�Rk Zel�Ha filed Critical Leyla A�An Nac�Ye
Priority to TR2011/01874A priority Critical patent/TR201101874A2/tr
Publication of TR201101874A2 publication Critical patent/TR201101874A2/tr
Priority to PCT/TR2011/000277 priority patent/WO2012115597A1/en
Priority to DE112011104956.0T priority patent/DE112011104956T5/de
Priority to US13/636,695 priority patent/US20130323208A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Buluş; yüzeysel mesane tümörlerin tedavisi için bağışıklık sistemi hücrelerini güçlü bir şekilde uyaran, insanda patojen olmayan, American Type Culture Collection (ATCC) katalog No: 51384 ile kayıtlı suşun tüm belirleyici özelliklerine sahip bir mikobakteri susu olan M. Brumae'nin kullanılmasıdır.
TR2011/01874A 2011-02-25 2011-02-25 Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri. TR201101874A2 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2011/01874A TR201101874A2 (tr) 2011-02-25 2011-02-25 Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.
PCT/TR2011/000277 WO2012115597A1 (en) 2011-02-25 2011-12-20 Mycobacterium brumae cell wall extracts that can be used in therapy of superficial bladder cancers
DE112011104956.0T DE112011104956T5 (de) 2011-02-25 2011-12-20 Mycobakterium Brumae Zellwandextrakte, die in der Therapie von oberflächlichem Blasenkrebs verwendet werden können
US13/636,695 US20130323208A1 (en) 2011-02-25 2011-12-20 Mycobacterium brumae cell wall extracts that can be used in therapy of superficial bladder cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/01874A TR201101874A2 (tr) 2011-02-25 2011-02-25 Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.

Publications (1)

Publication Number Publication Date
TR201101874A2 true TR201101874A2 (tr) 2011-08-22

Family

ID=44950469

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/01874A TR201101874A2 (tr) 2011-02-25 2011-02-25 Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.

Country Status (4)

Country Link
US (1) US20130323208A1 (tr)
DE (1) DE112011104956T5 (tr)
TR (1) TR201101874A2 (tr)
WO (1) WO2012115597A1 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2391108B1 (es) * 2012-07-26 2013-10-07 Universitat Autonoma De Barcelona Uso de mycobacterium brumae para el tratamiento del cáncer de vejiga
US20240024449A1 (en) * 2022-07-20 2024-01-25 Immunology Diagnostics, LLC Methods and compositions for improving immune system function

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU691797B2 (en) 1993-01-29 1998-05-28 Vetrepharm, Inc. Immunotherapeutic composition
CA2160082C (en) 1994-10-07 1998-11-10 Melvin E. Klegerman Mixture having antitumor activities
RU2112543C1 (ru) 1996-09-26 1998-06-10 Александр Григорьевич Хоменко Иммуномодулирующее лекарственное средство
AUPO359396A0 (en) * 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
DE69829316T2 (de) 1998-02-18 2006-04-13 Bioniche Life Sciences Inc., Belleville Behandlung des harnblasenkrebses durch mycobacterium phlei zellwand
CN1339583A (zh) 2001-09-28 2002-03-13 靳凤烁 重组耻垢分支杆菌其制备及在治疗膀胱肿瘤药物中的应用
UA79952C2 (en) * 2001-12-10 2007-08-10 Kabulesh Mafatlal Khamar MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT
EP1350839B1 (en) * 2002-04-05 2010-06-02 Institut Pasteur Identification of virulence associated regions RD1 and RD5 enabling the development of improved vaccines of M. bovis BCG and M. microti
WO2007134132A2 (en) * 2006-05-12 2007-11-22 Genentech, Inc. Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors

Also Published As

Publication number Publication date
WO2012115597A1 (en) 2012-08-30
US20130323208A1 (en) 2013-12-05
DE112011104956T5 (de) 2014-01-23

Similar Documents

Publication Publication Date Title
MY184101A (en) Indoles
EA201791843A2 (ru) Способы повышения эффективности folr1 терапии рака
UY34352A (es) 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante
PH12014502169A1 (en) N-cyclylamides as nematicides
EA201171367A1 (ru) Винилиндазолильные соединения
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
MX366435B (es) Papel tisu suave y voluminoso.
EA201200999A1 (ru) Способы лечения рака молочной железы
MY171561A (en) Conjugates for treating diseases caused by psma expressing cells
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
EP2614143A4 (en) IMMUNOTHERAPY OF CANCER WITH GENETICALLY MANIPULATED GD2-SPECIFIC T CELLS
EA201300810A1 (ru) Противораковая терапия с использованием двойных ингибиторов киназ аврора/мек
EP3683320A3 (en) Mirna fingerprint in the diagnosis of lung cancer
EA201201357A1 (ru) Антитела к cd40
HK1199290A1 (en) Methods and compositions for the treatment and diagnosis of breast cancer
MX394137B (es) Compuestos y composiciones novedosas para atacar las células madre del cáncer.
EA201290642A1 (ru) Соединения и способы
MX337203B (es) Novedosas moleculas inhbidoras de jnk.
MX2022002138A (es) Estandares de antigeno prostatico y sus usos.
WO2015093948A3 (en) Means and methods for typing a breast cancer patient and assigning therapy based on the typing
WO2012075117A3 (en) Small molecule-polymer conjugates and methods of making same
CL2012002753A1 (es) Uso de compuestos derivados de anilinopirimidina sustituida con sulfoximina, inhibidores de pan-cdk, para tratar tumores tales como carcinomas de mama, pancreas, riñon, melanomas malignos, entre otros.
MX350807B (es) Composiciones y metodos para el analisis de cancer de prostata.
TN2013000201A1 (en) Methods and compositions for drying coal
TR201101874A2 (tr) Yüzeyel mesane tümorü tedavisinde kullanılabilecek mycobacterıum(mikobakteri) brumae hücre duvarı ekstreleri.